CareZone can’t accept insurance without a pharmacy benefits manager, which is why it teamed up with Express Scripts. However, Express Scripts is accusing CareZone of misrepresenting itself as a retail pharmacy when it was actually a mail-order pharmacy — the same claim Express Scripts made against PillPack in 2016 — and is alleging it shipped drugs to states it wasn’t licensed in.
CareZone CEO Jonathan Schwartz is denying these allegations and told CNBC his company has licenses in all 50 states. Mr. Schwartz also disputes the PBM’s claim that CareZone isn’t a retail pharmacy. He started the company in 2012 as a medication management app, then later created CareZone Pharmacy Services to deliver drugs. Customers use the app to sign a consent form that enables CareZone to deliver their medications.
Mr. Schwartz said CareZone would lose nearly 900 customers, many of whom are low-income patients in rural areas, some with multiple chronic illnesses. He sent customers a email in mid-June to inform them of Express Scripts’ plans — which would go in effect July 13 — and urging them to call the PBM to keep its deal with CareZone.
More articles on pharmacy:
Cigna CEO: Express Scripts deal leaves very little overlap for antitrust argument
Express Scripts to lay off 456 employees: 3 things to know
DOJ requests information from Cigna, Express Scripts as merger review continues
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.